| Boris Royak, MD | |
|
25700 Science Park Dr Ste 210, Beachwood, OH 44122-7328 | |
| (216) 450-1613 | |
| (216) 450-1614 |
| Full Name | Boris Royak |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 25 Years |
| Location | 25700 Science Park Dr Ste 210, Beachwood, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528091899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 35-081164 (Ohio) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 35.081164 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Recovery Concepts, Llc | 5991005860 | 25 |
News Archive
The World Health Organization (WHO) has named antimicrobial resistance one of the most important threats to human health. We therefore need to find new compounds that can be used as future alternatives to conventional antibiotics.
The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.
"Despite the gains associated with antiretroviral treatments (ART) over the last decade, HIV/AIDS remains the leading cause of death among young and middle-aged adults in the Caribbean, warns a new U.N. report" that was released during the 10th Annual General Meeting of the Pan Caribbean Partnership Against HIV and AIDS (PANCAP) that concluded on Tuesday, Inter Press Service reports (Richards, 11/3).
Novavax, Inc. has announced favorable results from a Phase IIa human clinical trial of its seasonal influenza VLP (trivalent) vaccine candidate.
› Verified 5 days ago
| Entity Name | Advanced Recovery Concepts, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619348414 PECOS PAC ID: 5991005860 Enrollment ID: O20151125000337 |
News Archive
The World Health Organization (WHO) has named antimicrobial resistance one of the most important threats to human health. We therefore need to find new compounds that can be used as future alternatives to conventional antibiotics.
The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.
"Despite the gains associated with antiretroviral treatments (ART) over the last decade, HIV/AIDS remains the leading cause of death among young and middle-aged adults in the Caribbean, warns a new U.N. report" that was released during the 10th Annual General Meeting of the Pan Caribbean Partnership Against HIV and AIDS (PANCAP) that concluded on Tuesday, Inter Press Service reports (Richards, 11/3).
Novavax, Inc. has announced favorable results from a Phase IIa human clinical trial of its seasonal influenza VLP (trivalent) vaccine candidate.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Boris Royak, MD 25700 Science Park Dr Ste 210, Beachwood, OH 44122-7328 Ph: (216) 450-1613 | Boris Royak, MD 25700 Science Park Dr Ste 210, Beachwood, OH 44122-7328 Ph: (216) 450-1613 |
News Archive
The World Health Organization (WHO) has named antimicrobial resistance one of the most important threats to human health. We therefore need to find new compounds that can be used as future alternatives to conventional antibiotics.
The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.
"Despite the gains associated with antiretroviral treatments (ART) over the last decade, HIV/AIDS remains the leading cause of death among young and middle-aged adults in the Caribbean, warns a new U.N. report" that was released during the 10th Annual General Meeting of the Pan Caribbean Partnership Against HIV and AIDS (PANCAP) that concluded on Tuesday, Inter Press Service reports (Richards, 11/3).
Novavax, Inc. has announced favorable results from a Phase IIa human clinical trial of its seasonal influenza VLP (trivalent) vaccine candidate.
› Verified 5 days ago
Dr. Harold Mars, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3609 Park East Dr, Suite 517, Beachwood, OH 44122 Phone: 216-831-6085 Fax: 216-831-6172 | |
Emily Lauren Sykes, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 25700 Science Park Dr Ste 210, Beachwood, OH 44122 Phone: 216-450-1613 Fax: 216-450-1614 | |
Mrs. Dori J Supan, LISW Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24400 Highpoint Rd, Ste 6, Beachwood, OH 44122 Phone: 216-831-6550 Fax: 216-831-6133 | |
Dr. Stephen B. Zinn, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 29425 Chagrin Blvd, Suite 301, Beachwood, OH 44122 Phone: 216-292-0610 Fax: 216-292-0627 | |
Benjamin A. Spinner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 29425 Chagrin Blvd, Suite 301, Beachwood, OH 44122 Phone: 216-292-0610 | |
Dr. Jonathan W Sirkin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24200 Chagrin Blvd, The Office Place, Beachwood, OH 44122 Phone: 216-283-7690 Fax: 216-766-6084 | |
Jerry M Zober, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 29425 Chagrin Blvd, Suite 301, Beachwood, OH 44122 Phone: 216-292-0610 Fax: 216-292-0627 |